MENU
GDP & GMP
SERVICES
inglasiasupporting global quality in the
manufacture and distribution of medicine

Medicinal Products…. Counterfeits…. Patient Safety: is increased dialogue between the Pharmaceutical Industry and Healthcare Professionals the answer? by Sanjay Nadarajah

Q:What does the Pharmaceutical industry have in common with the Big Bang theory of the Universe? A: Explosive expansion. In …

Read more >

Typical Controls Applied In Packaging Operations – Drug Products and Medical Devices

1.      Responsibilities The Site Quality Management and Site Management are responsible for ensuring that the principles and methods detailed here …

Read more >

Principios del acercamiento basado en riesgos en la evaluación de sistemas de calidad en las compañías farmacéuticas – por Dr Judy Wu

El crecimiento acelerado de las compañías farmacéuticas, y de la industria ha resultado en la necesidad de herramientas de manejo …

Read more >

Principles of risk-based approach in the assessment of quality systems in pharmaceutical companies – by Dr Judy Wu

Recent rapid growth of pharmaceutical companies, and the industry has resulted in the need for more efficient management tools and …

Read more >

Key Forthcoming Changes to the EU GDP Commission Guidelines – by Sanjay Nadarajah

(Sanjay Nadarajah’s article was originally published in the RQA’s Quasar magazine, January 2013 edition) First published in the Official Journal of …

Read more >

Writing an article for inglasia

Articles should be submitted by email to info@inglasia.com. The article can be on see any topic on Good Manufacturing and …

Read more >